Findings A study led by researchers from the UCLA Health Jonsson Comprehensive Cancer Center sheds light on testosterone recovery following androgen deprivation therapy (ADT) in men undergoing ...
At the time, the oral therapy was touted as the first approved ... Pfizer has notified regulatory authorities of the market withdrawal. The company is still investigating the new clinical findings ...
A new study sheds light on testosterone recovery following androgen deprivation therapy (ADT) in men undergoing radiotherapy for prostate cancer, providing key insights for optimizing patient care.